Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Recently developed genomics-based tools are allowing repositioning of Food and Drug Administration (FDA)-approved drugs as cancer treatments, which were employed to identify drugs that target cancer stem cells (CSCs) of breast cancer. Gene expression datasets of CSCs from six studies were subjected...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat-Nakshatri, Poornima, Goswami, Chirayu P., Badve, Sunil, Sledge, George W., Nakshatri, Harikrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965360/
https://www.ncbi.nlm.nih.gov/pubmed/23982413
http://dx.doi.org/10.1038/srep02530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965360/
https://www.ncbi.nlm.nih.gov/pubmed/23982413
http://dx.doi.org/10.1038/srep02530

Ejemplares similares